In The Lancet Respiratory Medicine, Olivier Sitbon and colleagues1 present the results of a randomised, phase 2b clinical trial (ELEVATE-2) that compared the safety and efficacy of pulmonary arterial ...
CHDs are the most common type of congenital condition, seen in about 1% of all newborns in the United States. CHDs range in severity; some mild CHDs resolve on their own, but complicated ...